Annual long term liabilities:
$1.70B-$47.83M(-2.73%)Summary
- As of today (May 31, 2025), SRPT annual total long term liabilities is $1.70 billion, with the most recent change of -$47.83 million (-2.73%) on December 31, 2024.
- During the last 3 years, SRPT annual long term liabilities has fallen by -$63.48 million (-3.59%).
- SRPT annual long term liabilities is now -19.78% below its all-time high of $2.12 billion, reached on December 31, 2022.
Performance
SRPT Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$1.72B+$13.33M(+0.78%)Summary
- As of today (May 31, 2025), SRPT quarterly total long term liabilities is $1.72 billion, with the most recent change of +$13.33 million (+0.78%) on March 1, 2025.
- Over the past year, SRPT quarterly long term liabilities has increased by +$62.59 million (+3.78%).
- SRPT quarterly long term liabilities is now -19.15% below its all-time high of $2.12 billion, reached on December 31, 2022.
Performance
SRPT quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
SRPT Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.7% | +3.8% |
3 y3 years | -3.6% | -1.6% |
5 y5 years | +130.3% | +14.8% |
SRPT Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -19.8% | at low | -19.1% | +3.8% |
5 y | 5-year | -19.8% | +130.3% | -19.1% | +15.6% |
alltime | all time | -19.8% | >+9999.0% | -19.1% | >+9999.0% |
SRPT Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $1.72B(+0.8%) |
Dec 2024 | $1.70B(-2.7%) | $1.70B(+1.5%) |
Sep 2024 | - | $1.68B(+1.2%) |
Jun 2024 | - | $1.66B(+0.3%) |
Mar 2024 | - | $1.65B(-5.5%) |
Dec 2023 | $1.75B(-17.5%) | $1.75B(-7.5%) |
Sep 2023 | - | $1.89B(+0.5%) |
Jun 2023 | - | $1.89B(+4.2%) |
Mar 2023 | - | $1.81B(-14.8%) |
Dec 2022 | $2.12B(+20.2%) | $2.12B(+0.1%) |
Sep 2022 | - | $2.12B(+23.0%) |
Jun 2022 | - | $1.72B(-1.1%) |
Mar 2022 | - | $1.74B(-1.3%) |
Dec 2021 | $1.77B(-2.2%) | $1.77B(-2.9%) |
Sep 2021 | - | $1.82B(-1.6%) |
Jun 2021 | - | $1.85B(-0.9%) |
Mar 2021 | - | $1.87B(+3.2%) |
Dec 2020 | $1.81B(+144.2%) | $1.81B(+19.6%) |
Sep 2020 | - | $1.51B(+1.7%) |
Jun 2020 | - | $1.49B(-0.7%) |
Mar 2020 | - | $1.50B(+102.2%) |
Dec 2019 | $739.87M(+69.7%) | $739.87M(+50.6%) |
Sep 2019 | - | $491.41M(+1.0%) |
Jun 2019 | - | $486.50M(+1.8%) |
Mar 2019 | - | $477.96M(+9.6%) |
Dec 2018 | $436.11M(+1.3%) | $436.11M(+1.7%) |
Sep 2018 | - | $428.67M(-3.3%) |
Jun 2018 | - | $443.43M(+2.6%) |
Mar 2018 | - | $432.33M(+0.4%) |
Dec 2017 | $430.42M(+3489.5%) | $430.42M(+1218.1%) |
Sep 2017 | - | $32.66M(+409.7%) |
Jun 2017 | - | $6.41M(-17.5%) |
Mar 2017 | - | $7.76M(-35.3%) |
Dec 2016 | $11.99M(-43.3%) | $11.99M(-12.8%) |
Sep 2016 | - | $13.75M(-12.3%) |
Jun 2016 | - | $15.68M(-18.5%) |
Mar 2016 | - | $19.24M(-9.0%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $21.14M(+101.1%) | $21.14M(-11.4%) |
Sep 2015 | - | $23.85M(-12.9%) |
Jun 2015 | - | $27.37M(+240.3%) |
Mar 2015 | - | $8.04M(-23.5%) |
Dec 2014 | $10.51M(+25.0%) | $10.51M(+3.8%) |
Sep 2014 | - | $10.13M(+26.9%) |
Jun 2014 | - | $7.98M(-7.9%) |
Mar 2014 | - | $8.67M(+3.1%) |
Dec 2013 | $8.41M(+246.4%) | $8.41M(+31.5%) |
Sep 2013 | - | $6.39M(+168.8%) |
Jun 2013 | - | $2.38M(-0.9%) |
Mar 2013 | - | $2.40M(-1.2%) |
Dec 2012 | $2.43M(-11.7%) | $2.43M(-0.8%) |
Sep 2012 | - | $2.45M(-0.9%) |
Jun 2012 | - | $2.47M(-8.6%) |
Mar 2012 | - | $2.70M(-1.7%) |
Dec 2011 | $2.75M(-6.3%) | $2.75M(-1.8%) |
Sep 2011 | - | $2.80M(-1.6%) |
Jun 2011 | - | $2.85M(-1.6%) |
Mar 2011 | - | $2.89M(-1.5%) |
Dec 2010 | $2.94M(+1.6%) | $2.94M(+0.1%) |
Sep 2010 | - | $2.93M(-0.9%) |
Jun 2010 | - | $2.96M(-1.8%) |
Mar 2010 | - | $3.01M(+4.2%) |
Dec 2009 | $2.89M(+14.9%) | $2.89M(+12.9%) |
Sep 2009 | - | $2.56M(+0.7%) |
Jun 2009 | - | $2.54M(+1.2%) |
Mar 2009 | - | $2.51M(-0.2%) |
Dec 2008 | $2.52M(+0.5%) | $2.52M(+0.2%) |
Sep 2008 | - | $2.51M(+0.1%) |
Jun 2008 | - | $2.51M(-1.7%) |
Mar 2008 | - | $2.55M(+1.9%) |
Dec 2007 | $2.50M | $2.50M(+19.9%) |
Sep 2007 | - | $2.09M(-0.8%) |
Jun 2007 | - | $2.11M(-2206.7%) |
Sep 1999 | - | -$100.00K(-103.2%) |
Mar 1997 | - | $3.10M |
FAQ
- What is Sarepta Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual long term liabilities year-on-year change?
- What is Sarepta Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly long term liabilities year-on-year change?
What is Sarepta Therapeutics annual total long term liabilities?
The current annual long term liabilities of SRPT is $1.70B
What is the all time high annual long term liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual total long term liabilities is $2.12B
What is Sarepta Therapeutics annual long term liabilities year-on-year change?
Over the past year, SRPT annual total long term liabilities has changed by -$47.83M (-2.73%)
What is Sarepta Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of SRPT is $1.72B
What is the all time high quarterly long term liabilities for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly total long term liabilities is $2.12B
What is Sarepta Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, SRPT quarterly total long term liabilities has changed by +$62.59M (+3.78%)